Skip to main content
SpringerLink
Log in

Bismuth triple and quadruple studies for Helicobacter pylori eradication in Canada

  • Chapter
Helicobacter pylori

  • 222 Accesses

Abstract

Since the discovery of Helicobacter pylori infection by Marshall and Warren1 there have been many attempts at eliminating this infection with different antibiotic combinations. Bismuth was one of the first agents used in this regard. When used in combination with other antibiotics it continues to be one of the choices for H. pylori treatment recommended by several recent Consensus Conferences2–4. Several studies on H. pylori eradication have been carried out in Canada but relatively few have examined combinations which include bismuth. The purpose of this chapter is to describe the different studies which have examined bismuth triple and quadruple therapies in Canada.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Marshall DJ, Warren JR. Unidentified curve bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–1314.

    Article  PubMed  CAS  Google Scholar 

  2. Current European Concepts in the Management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut. 1997;41:8–13.

    Article  Google Scholar 

  3. The Report of the Digestive Health Initiative International Update Conference on Helicobacter pylori. Gastroenterology. 1997;113(Suppl.):S4-8.

    Google Scholar 

  4. Hunt RH, Fallone CA, Thomson ABR. Canadian Helicobacter Study Group. Canadian Helicobacter pylori Consensus Conference Update: Infections in Adults. Can J Gastroenterol. 1999;13:213–217.

    PubMed  CAS  Google Scholar 

  5. Israel BM, Hassall E. Treatment and long-term follow-up of Helicobacter pylori associated duodenal ulcer disease in children. J Pediatr. 1993;123:53–58.

    Article  PubMed  CAS  Google Scholar 

  6. Dunne D, Veldhuyzen van Zanten S. The efficacy of bismuth triple therapy for Helicobacter pylori infection. Can J Gastroenterol. 1996;10(Suppl. A):57A.

    Google Scholar 

  7. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. 1992;87:1716–1727.

    PubMed  CAS  Google Scholar 

  8. Veldhuyzen van Zanten S, Malatjalian D, Tanton R et al. The effect of eradication of Helicobacter pylori (Hp) on symptoms of non-ulcer dyspepsia (NUD): a randomized, double-blind, placebo controlled trial. Gastroenterology. 1995;108:A250.

    Article  Google Scholar 

  9. Chiba N, Marshall C. Omeprazole, bismuth, metronidazole and tetracycline (OBMT) quadruple therapy given twice daily for H. pylori eradication in a community gastroenterology practice. Gastroenterology. 1998;114:A91.

    Article  Google Scholar 

  10. Lahaie RG, Farley A. Efficacy of OBMT in a twice daily (BID) dosage for the eradication of H. pylori: a preliminary study. Gastroenterology. 1998;114:A190.

    Article  Google Scholar 

  11. Fallone CA, Loo VG, Jospeh L, Barkun J, Kostyk R, Barkun AN. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized, controlled trial. Clin Invest Med. 1999;22:185–194.

    PubMed  CAS  Google Scholar 

  12. Veldhuyzen van Zanten S, Farley A, Marcon N et al. Efficacy of colloidal bismuth subcitrate, metronidazole and tetracycline HC1 in eradication of H. pylori: a randomized, placebo-controlled study. Gastroenterology. 1998;114:A322.

    Article  Google Scholar 

  13. Lahaie R, Farley A, Dallaire C et al. Bismuth-based quadruple therapy with colloidal bismuth substrate + tetracycline 4-metronidazole (M) + omeprazole in eradication of M-sensitive and M-resistant Helicobacter pylori. Gastroenterology. 1999;116:A227.

    Google Scholar 

  14. Bardhan KD, Dallaire C, Eisold H, Duggan AE. GR122311X (ranitidine bismuth citrate) with clarithromycin for the treatment of duodenal ulcer. Gastroenterology. 1995;108:A53.

    Google Scholar 

  15. Paré P, Farley A, Romaozinho JM, Bardhan KD, French PC, Roberts PM. Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori. Aliment Pharmacol Ther. 1999;13:1071–1078.

    Article  PubMed  Google Scholar 

  16. Lind T, Veldhuyzen van Zanten S, Unge P et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter. 1996;1:138–144.

    Google Scholar 

  17. van Zanten SJ, Bradette M, Farley A et al The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther. 1999;13:289–295.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. A. Fallone
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Gastroenterology, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada

    Richard H. Hunt (Professor of Medicine Director) (Professor of Medicine Director)

  2. Department of Gastroenterology and Hepatology, Academic Medical Centre, 9 Meibergdreef, 1105 AZ, Amsterdam, The Netherlands

    Guido N. J. Tytgat (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Fallone, C.A. (2000). Bismuth triple and quadruple studies for Helicobacter pylori eradication in Canada. In: Hunt, R.H., Tytgat, G.N.J. (eds) Helicobacter pylori. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3927-4_61

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3927-4_61

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5753-0

  • Online ISBN: 978-94-011-3927-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation